NaSSA (noradrenergic and specific serotonergic antidepressant)
A NaSSA (noradrenergic and specific serotonergic antidepressant) blocks receptors that normally hold back the release of norepinephrine and serotonin, which raises the activity of both. Specific refers to how it acts on serotonin receptors: rather than affecting most of them, it mainly blocks two types, called 5-HT2 and 5-HT3. It also blocks histamine, which is why it causes sleepiness and a bigger appetite. Mirtazapine, sold as Remeron, is the NaSSA people mean in practice.
Also called: Noradrenergic and specific serotonergic antidepressant, NaSSA antidepressant.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
What is the difference between a NaSSA and an SSRI?
SSRIs block the reuptake of serotonin, which leaves more of it between nerve cells. Mirtazapine does not work that way. Its US label says the mechanism of action in depression is unclear, and points to its work as an antagonist at central presynaptic alpha-2 adrenergic inhibitory autoreceptors, which enhances central noradrenergic and serotonergic activity.
It blocks histamine H1 receptors as well, and that is the part you feel. The label says its prominent somnolent effects may be explained by that inhibition of histamine receptors, which is why sleepiness can be there from the first doses while any lift in mood takes weeks. Its half-life is about 20 to 40 hours, long enough that a night-time dose is still in you the next morning.
What is NaSSA medicine used for?
In the US, mirtazapine is approved for major depressive disorder in adults. The label says it is not approved for use in children, and that safety and effectiveness in pediatric patients have not been established.
If yours was prescribed for something else, sleep or appetite for instance, that use is off label, which is worth asking your prescriber about directly: what they expect it to do for you, and how long they want to give it.
What is the downside of mirtazapine?
Sleepiness and weight gain, mostly. In the 6-week US trials in the Remeron label, somnolence was reported by 54% of people on mirtazapine against 18% on placebo, a pill with no drug in it. Weight gain of 7% or more of body weight was reported in 7.5% of people on mirtazapine and in none of those on placebo, and the label says the medication has been associated with increased appetite as well.
Because of the sleepiness, the label tells prescribers to caution people about activities that need alertness, including driving and operating hazardous machinery, until they know how the medication affects them.
The label also records reactions on stopping the drug, particularly an abrupt stop: dizziness, abnormal dreams, sensory disturbances, agitation, anxiety, fatigue, confusion, headache, tremor, nausea, vomiting and sweating. Its answer is in the next line, that the dose is reduced gradually rather than stopped abruptly whenever possible, so the end of mirtazapine is something to plan with your prescriber before you get there.
Is mirtazapine the strongest antidepressant?
No antidepressant holds that title. In a 2018 review in The Lancet that pooled 522 trials and 116,477 people, all 21 antidepressants studied worked better than placebo, and mirtazapine was one of seven that came out ahead in head-to-head comparisons, with agomelatine, amitriptyline, escitalopram, paroxetine, venlafaxine and vortioxetine. The gaps between the active drugs themselves were smaller once the placebo-controlled trials were counted in.
Those are averages across thousands of people, not a forecast for one. Which antidepressant fits you depends on how you respond to it and which side effects you can live with.
What to do
Ask your prescriber what to do about morning grogginess and a bigger appetite on mirtazapine, and when they want to review how it is working. Tell them if a change in appetite, energy or the way your clothes fit keeps up. If you're having thoughts of harming yourself, contact emergency services or a crisis line straight away. In the US, call or text 988. In the UK, call Samaritans on 116 123. Elsewhere, call your local emergency number or find a crisis line near you.
Read the Remeron (mirtazapine) guide
How withClaro helps
- Track appetite and sleepiness next to your dose
- Share a clear record with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Remeron and RemeronSolTab (mirtazapine): prescribing information. FDA / DailyMed, 2021.
- Cipriani A, Furukawa TA, Salanti G, et al.. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 2018.
All glossary terms